Taglietti Marco

SEC source: 0001214659-26-007394 · marketforms-73386.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,500

Underlying: Common Stock · 50,500 shares

Expires 2036-06-10

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001214659-25-009118 · marketforms-69475.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 42,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001214659-24-011220 · marketforms-66327.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2034-06-20

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001214659-23-008795 · marketforms-61962.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001214659-22-008289 · marketforms-56518.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-22

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 22, 2023, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001209191-22-025903 · doc4.xml · derivative · entry 2

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2029-04-26

F1 · price: Reflects the purchase on April 26, 2022, of 75,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $3.00 per share of common stock and accompanying warrant.

SEC source: 0001209191-22-025903 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,068

F1 · price: Reflects the purchase on April 26, 2022, of 75,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $3.00 per share of common stock and accompanying warrant.

F2 · balance_after: Includes shares purchased under the issuer's ESPP, which did not require the filing of a Form 4 for such purchase.

SEC source: 0001209191-22-007735 · doc4.xml · derivative · entry 2

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,000

Underlying: Common Stock · 232,000 shares

Expires 2032-02-03

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

SEC source: 0001209191-22-007735 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,968

F1 · shares: Represents restricted stock units that vest 50% per year over two years on the anniversary of the date of grant.

SEC source: 0001214659-21-006720 · marketforms-53153.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-06-15

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 15, 2022, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001214659-21-003149 · marketforms-51885.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,500

Underlying: Common Stock · 28,500 shares

Expires 2031-03-11

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 11, 2022.

SEC source: 0001209191-21-006718 · doc4.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,000

Underlying: Common Stock · 170,000 shares

Expires 2031-01-28

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

SEC source: 0001209191-20-064960 · doc4.xml · derivative · entry 3

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2024-06-21

F1 · price: Reflects the purchase on December 21, 2020 of 40,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant).

SEC source: 0001209191-20-064960 · doc4.xml · derivative · entry 2

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2021-12-21

F1 · price: Reflects the purchase on December 21, 2020 of 40,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant).

SEC source: 0001209191-20-064960 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,668

F1 · price: Reflects the purchase on December 21, 2020 of 40,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant).

SEC source: 0000899243-20-012457 · doc4.xml · derivative · entry 3

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series E Convertible Preferred Stock has no expiration date and a stated value of $1,000 (the "Stated Value"). On May 8, 2020, reporting person converted the Series E Preferred Stock into that number of shares of Delcath Systems Inc. common stock determined by dividing the Stated Value by the conversion price of $10.00.

F1 · derivative.exercise_date: Each share of the Series E Convertible Preferred Stock has no expiration date and a stated value of $1,000 (the "Stated Value"). On May 8, 2020, reporting person converted the Series E Preferred Stock into that number of shares of Delcath Systems Inc. common stock determined by dividing the Stated Value by the conversion price of $10.00.

F1 · derivative.expiration_date: Each share of the Series E Convertible Preferred Stock has no expiration date and a stated value of $1,000 (the "Stated Value"). On May 8, 2020, reporting person converted the Series E Preferred Stock into that number of shares of Delcath Systems Inc. common stock determined by dividing the Stated Value by the conversion price of $10.00.

F1 · derivative.underlying_shares: Each share of the Series E Convertible Preferred Stock has no expiration date and a stated value of $1,000 (the "Stated Value"). On May 8, 2020, reporting person converted the Series E Preferred Stock into that number of shares of Delcath Systems Inc. common stock determined by dividing the Stated Value by the conversion price of $10.00.

SEC source: 0000899243-20-012457 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the Series E Convertible Preferred Stock has no expiration date and a stated value of $1,000 (the "Stated Value"). On May 8, 2020, reporting person converted the Series E Preferred Stock into that number of shares of Delcath Systems Inc. common stock determined by dividing the Stated Value by the conversion price of $10.00.

F2 · balance_after: Reflects a one-for-seven hundred (1:700) reverse stock split effected on December 24, 2019.

SEC source: 0001209191-20-006266 · doc4.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 900,000

Underlying: Common Stock · 900,000 shares

Expires 2030-01-30

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

SEC source: 0001209191-19-060615 · doc4.xml · derivative · entry 2

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,667

Underlying: Common Stock · 166,667 shares

Expires not disclosed

F1 · price: Reflects the purchase on December 12, 2019, of 166,667 shares of the issuer's common stock at a public offering price of $0.90 per share of common stock and accompanying warrant.

F2 · derivative.expiration_date: The warrant expires on the earlier of (i) such date that is six months after the issuer publicly announces the approval from the U.S. Food and Drug Administration for ibrexafungerp for the treatment of vulvovaginal candidiasis and (ii) June 12, 2023.

SEC source: 0001209191-19-060615 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 693,682

F1 · price: Reflects the purchase on December 12, 2019, of 166,667 shares of the issuer's common stock at a public offering price of $0.90 per share of common stock and accompanying warrant.

SEC source: 0001209191-19-047071 · doc4.xml · nonDerivative · entry 2

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 526,015

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.11 to $1.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001209191-19-047071 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 516,515

SEC source: 0001209191-19-046455 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 516,015

SEC source: 0000899243-19-020491 · doc4.xml · derivative · entry 2

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires not disclosed

F3 · derivative.exercise_price: The warrant was included together with the purchase of Series E Convertible Preferred Stock purchased by the reporting person for $1,000 per share. The purchase of shares of Series E Convertible Preferred Stock was accompanied by a right to purchase 16,666.67 shares of common stock for an aggregate of 1,000,000 shares of common stock. The exercise price of each share under the warrant is $0.06, subject to adjustment in accordance with the terms of the warrant and is exercisable at any time from the date that the issuer effects a reverse stock split through 5:00 p.m. (NYC time) on the fifth anniversary of the date of the reverse stock split.

F2 · kind: The purchase was made in a private (PIPE) transaction with the issuer in which the issuer sold Series E Convertible Preferred Stock and warrants. The transactions contemplated by the PIPE transaction were reported on a current report on Form 8-K filed with the SEC by the issuer on each of July 11, 2019 and July 22, 2019.

F3 · price: The warrant was included together with the purchase of Series E Convertible Preferred Stock purchased by the reporting person for $1,000 per share. The purchase of shares of Series E Convertible Preferred Stock was accompanied by a right to purchase 16,666.67 shares of common stock for an aggregate of 1,000,000 shares of common stock. The exercise price of each share under the warrant is $0.06, subject to adjustment in accordance with the terms of the warrant and is exercisable at any time from the date that the issuer effects a reverse stock split through 5:00 p.m. (NYC time) on the fifth anniversary of the date of the reverse stock split.

F3 · derivative.exercise_date: The warrant was included together with the purchase of Series E Convertible Preferred Stock purchased by the reporting person for $1,000 per share. The purchase of shares of Series E Convertible Preferred Stock was accompanied by a right to purchase 16,666.67 shares of common stock for an aggregate of 1,000,000 shares of common stock. The exercise price of each share under the warrant is $0.06, subject to adjustment in accordance with the terms of the warrant and is exercisable at any time from the date that the issuer effects a reverse stock split through 5:00 p.m. (NYC time) on the fifth anniversary of the date of the reverse stock split.

F3 · derivative.expiration_date: The warrant was included together with the purchase of Series E Convertible Preferred Stock purchased by the reporting person for $1,000 per share. The purchase of shares of Series E Convertible Preferred Stock was accompanied by a right to purchase 16,666.67 shares of common stock for an aggregate of 1,000,000 shares of common stock. The exercise price of each share under the warrant is $0.06, subject to adjustment in accordance with the terms of the warrant and is exercisable at any time from the date that the issuer effects a reverse stock split through 5:00 p.m. (NYC time) on the fifth anniversary of the date of the reverse stock split.

SEC source: 0000899243-19-020491 · doc4.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60

Underlying: Common Stock · 1,000,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of the Series E Convertible Preferred Stock, par value of $0.01 per share, has a stated value of $1,000 (the "Stated Value") and is convertible at any time at the option of the holder into the number of shares of Delcath common stock determined by dividing the Stated Value by the conversion price of $0.06, subject to certain limitations and adjustments contemplated within the Certificate of Designation.

F2 · kind: The purchase was made in a private (PIPE) transaction with the issuer in which the issuer sold Series E Convertible Preferred Stock and warrants. The transactions contemplated by the PIPE transaction were reported on a current report on Form 8-K filed with the SEC by the issuer on each of July 11, 2019 and July 22, 2019.

F1 · derivative.exercise_date: Each share of the Series E Convertible Preferred Stock, par value of $0.01 per share, has a stated value of $1,000 (the "Stated Value") and is convertible at any time at the option of the holder into the number of shares of Delcath common stock determined by dividing the Stated Value by the conversion price of $0.06, subject to certain limitations and adjustments contemplated within the Certificate of Designation.

F4 · derivative.expiration_date: The Series E Convertible Preferred Stock has no expiration date.

F3 · derivative.underlying_shares: The warrant was included together with the purchase of Series E Convertible Preferred Stock purchased by the reporting person for $1,000 per share. The purchase of shares of Series E Convertible Preferred Stock was accompanied by a right to purchase 16,666.67 shares of common stock for an aggregate of 1,000,000 shares of common stock. The exercise price of each share under the warrant is $0.06, subject to adjustment in accordance with the terms of the warrant and is exercisable at any time from the date that the issuer effects a reverse stock split through 5:00 p.m. (NYC time) on the fifth anniversary of the date of the reverse stock split.

SEC source: 0001209191-19-025201 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 506,000

SEC source: 0001209191-19-011129 · doc4.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 700,000

Underlying: Common Stock · 700,000 shares

Expires 2029-02-14

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

SEC source: 0000899243-19-002728 · doc4.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2029-02-01

F1 · derivative.exercise_date: The stock options vest in equal amounts of 8,333 options for 11 consecutive months commencing on the one month anniversary of the grant date, and the balance of the options (8,337) vesting on the 12 month anniversary of the grant date. Options are immediately exercisable upon vesting.

SEC source: 0001209191-19-003517 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 480,000

SEC source: 0001209191-19-000039 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 455,000

SEC source: 0001209191-18-048444 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 429,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.26 to $1.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001209191-18-018708 · doc4.xml · derivative · entry 3

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2023-03-08

F1 · price: Reflects the purchase on March 8, 2018, of 100,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant).

SEC source: 0001209191-18-018708 · doc4.xml · derivative · entry 2

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2019-03-14

F1 · price: Reflects the purchase on March 8, 2018, of 100,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant).

SEC source: 0001209191-18-018708 · doc4.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 404,000

F1 · price: Reflects the purchase on March 8, 2018, of 100,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant).

SEC source: 0001209191-18-009630 · doc4.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,000

Underlying: Common Stock · 375,000 shares

Expires 2028-02-08

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

SEC source: 0001178253-17-000020 · wf-form4_150637165803274.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,000

SEC source: 0001178253-17-000019 · wf-form4_150358132152635.xml · nonDerivative · entry 2

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,000

SEC source: 0001178253-17-000019 · wf-form4_150358132152635.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 287,007

SEC source: 0001178253-17-000018 · wf-form4_150297672592049.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 287,000

SEC source: 0001178253-17-000009 · wf-form4_149485065910342.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,000

SEC source: 0001628280-17-000755 · wf-form4_148606339727714.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 360,000

Underlying: Common Stock · 360,000 shares

Expires 2027-01-31

F1 · derivative.exercise_date: 2.08% of the shares subject to the option vest monthly for 48 months as measured from the date of grant.

SEC source: 0001628280-16-022131 · wf-form4_148240472143546.xml · nonDerivative · entry 1

Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.28 to $3.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.